Abstract:OBJECTIVE:To compare the CC-chemokine ligand 18 (CCL18) expression in the serum and malignant pleural effusion (MPE) of NSCLC patients and explore its regulatory effect on differentiation of monocyte-derived dendritic cells (Mo-DC).METHODS:CCL18 levels in the serum and MPE from 62 NSCLC patients were quantitated by immunoassay. CCL18 in sera from 26 healthy individuals, 28 exudative pleural effusions from inflammatory pulmonary diseases and 17 transudative pleural effusions from non-inflammatory diseases were used as control. Mo-DC was generated by culturing NSCLC-derived monocytes with GM-CSF and IL-4 in the presence or absence of CCL18. The mean fluorescent intensity (MFI) of CD14, CD80, CD83, CD86 and HLA-DR were analyzed by flow cytometry (FCM). Mo-DC was then co-cultured with purified T cells and the percence of CD25(+)FoxP3(+) cells was assayed by FCM.RESULTS:CCL18 levels in the sera of NSCLC patients and healthy individuals were (132.70 ± 15.52) ng/ml and (18.44 ± 0.99) ng/ml, respectively (P < 0.001). The levels of CCL18 in MPE, exudative PE and transudative PE were (155.6 ± 13.58) ng/ml, (190.4 ± 22.33) ng/ml and (20.89 ± 3.03) ng/ml, respectively. CCL18 in the MPE was significantly higher than that in transudates (P < 0.001), however, no significant difference was observed between CCL18 expression in exudative PE and MPE (P = 0.172). Of note, a moderate positive correlation (r = 0.421, P < 0.01) was observed between CCL18 levels in the paired MPE and serum of NSCLC. In the healthy control group, Mo-DC cultured in the presence of CCL18 showed 31.4 ± 15.8 (MFI) of CD14 expression, which was significantly higher than that in Mo-DC cultured in the absence of CCL18 (18.5 ± 8.9, P < 0.05). In contrast, the expressions of MFI of CD80, CD83, CD86 and HLA-DR were significantly decreased upon CCL18 induction (P < 0.05). In the NSCLC group, GM-CSF+IL-4+CCL18 induced a MFI of 45.2 ± 13.8 of CD14 expression in Mo-DC, which was also significantly higher than that of GM-CSF+ IL-4 induction (22.6 ± 10.5, P < 0.01). Similarly, the expressions of MFI of CD80, CD83, CD86 and HLA-DR were significantly decreased in the presence of CCL18 (P < 0.05). Furthermore, the MFI of CD14, CD83, CD86 and HLA-DR had significant differences between GM-CSF/IL-4/CCL18-induced Mo-DC derived from NSCLC patients and healthy control (P < 0.05). Finally, CD4(+) T cells co-cultured with NSCLC-derived, GM-CSF/IL-4/CCL18-treated Mo-DC had significantly higher percent of CD25(+)FoxP3(+) cells compared with that of CD4(+) T cells stimulated with Mo-DC induced by GM-CSF/IL-4(P < 0.01).CONCLUSIONS:CCL18 is present at a high level in MPE and serum of NSCLC patients complicated with pleural effusion and a moderate positive correlation exists between CCL18 levels in the two fluids. CCL18 inhibits maturation of Mo-DC, which consequently stimulates T cells to differentiate into CD25(+)FoxP3(+) regulatory T cells.

The Levels of IFN-γ and IL-10 from Dendritic Cells of Malignant Pleural Effusion

Human inflammatory dendritic cells in malignant pleural effusions induce Th1 cell differentiation

Induction of dendritic cells with IFN-alpha and GM-CSF from bone marrow mononuclear cells from patients with chronic myeloid leukemia

CD39+ Regulatory T Cells Suppress Generation and Differentiation of Th17 Cells in Human Malignant Pleural Effusion Via a LAP-dependent Mechanism

The Induction of Dendritic Cells with Ifn-Alpha and Gm-Csf from Bone Marrow Mononuclear Cells from Patients with Chronic Myeloid Leukemia.

Phenotype and metergasis of dendritic cells from peripheral blood of bladder carcinoma patients

The Levels of Interferon-gamma, Interleukin-2 Receptor, Interleukin-6 and Interleukin-10 in the patients with Malignant Pleural Effusion, Tuberculosis Effusion, Parapneumonic Effusion, and Lung Emphysema?

Dendritic cells derived from peripheral blood monocytes of patients with malignant tumor:a study of in vitro activity and function

The Diagnostic Value of MCP-1 and RANTES in Tuberculosis and Malignant Pleural Effusion

Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion.

Expressions and diagnostic value of the cytokines in tuberculous and malignant pleural effusion

Treg/Th17 imbalance in malignant pleural effusion partially predicts poor prognosis.

The expression levels of VEGF and ICAM-1 in pleural effusion

Alterations of Dendritic Cell Subsets in the Peripheral Circulation of Patients with Cervical Carcinoma.

In Vitro Immunosuppressive Effects of Malignant Ascites from Advanced Gastrointestinal Cancer Patients on Immune Function of Dendritic Cells

Expression of CC-chemokine Ligand 18 (CCL18) in the Serum and Pleural Effusion of Non-Small-cell Lung Cancer Patients and Its Regulatory Effect on the Differentiation of Monocyte-Derived Dendritic Cells

Clinical Study on Expressions of Γδtcr,cd1a,vegf,ifn-Γ and ADA Active in Pleural Effusion

The In fl uence of IFN-α on Blood Plasmacytoid Dendritic Cell in Chronic Myeloid Leukaemia

Influences of Interferon-α on Expression of Th Cytokines and CCR7 in Dendritic Cells from Patients with Chronic Myeloid Leukemia In Vitro

Cell Origins and Significance of IL-17 in Malignant Pleural Effusion

Immune Regulation of Interleukin-27 in Malignant Pleural Effusion